The Cancer Genome Atlas team reports in Nature on its study of 178 lung squamous cell carcinomas in which it found that such tumors are marked by complex genomic changes like rearrangements and copy number alterations. The TCGA team also notes that it found recurrent mutations in most samples, including TP53 mutations, and a number of pathways that are affected by those mutations. Further, the team reports that, for most tumors, it could identify potential therapeutic targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.